| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |